Autonomix Medical, Inc. carries no debt; cash flow comfortably covers obligations.

Autonomix Medical, Inc.'s free cash flow has decreased 48.60% from $-8.27M last year to $-12.29M, signaling decreasing performance

Autonomix Medical, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Autonomix Medical, Inc. has insufficient data to evaluate this check.

Autonomix Medical, Inc. has a net cash position, so leverage is healthy.

Autonomix Medical, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Autonomix Medical, Inc. has insufficient data to evaluate this check.

Autonomix Medical, Inc.'s short-term assets of $7.58M exceed its short-term liabilities of $1.71M

Autonomix Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Autonomix Medical, Inc.'s return on equity of -239.36%, is lower than 15.00%, indicating bad performance

Autonomix Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Autonomix Medical, Inc. has insufficient public price history to evaluate earnings stability.

Autonomix Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Autonomix Medical, Inc. has negative free cash flow, indicating cash burn

Autonomix Medical, Inc.'s yearly earnings has decreased 46.49% since last year from $-11.41M to $-16.71M, signaling decreasing performance

Autonomix Medical, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -288.97% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Autonomix Medical, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Autonomix Medical, Inc. has insufficient public price history to evaluate revenue consistency.

Autonomix Medical, Inc. has insufficient public price history to evaluate ROE consistency.

Autonomix Medical, Inc. has insufficient data to evaluate this check.

Autonomix Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Autonomix Medical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Autonomix Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Autonomix Medical, Inc. has insufficient data to evaluate this check.

Autonomix Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Autonomix Medical, Inc. has a price-to-book ratio of 0.86x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Autonomix Medical, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue